Phase 1

GSK3862995BA Study for GSK3862995B in Healthy Participants and Participants With Chronic Obstructive Pulmonary Disease

Sponsor:

GlaxoSmithKline

Code:

NCT06154837

Conditions

Pulmonary Disease, Chronic Obstructive

Eligibility Criteria

Sex: All

Age: 18 - 70+

Healthy Volunteers: Accepted

Interventions

GSK3862995B

Placebo

Study Details

Eligibility Criteria

Study Design

Interventions and Outcome Measures

Central Contacts and Locations

More Information

Trial information was received from ClinicalTrials.gov and was last updated on 2026-08-26. This information was provided to ClinicalTrials.gov by GlaxoSmithKline on 2026-05-29.